Cannabis for the Prophylactic Treatment of Migraine

NCT03972124 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Chronic Migraine

Interventions

DRUG: CBD 100 mg OD
DRUG: CBD 200 mg OD
DRUG: Placebo

Sponsor

University of Calgary